NXTM - Nxstage Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
27.39
-0.53 (-1.90%)
At close: 4:00PM EDT

27.39 0.00 (0.01%)
After hours: 4:46PM EDT

Stock chart is not supported by your current browser
Previous Close27.92
Open28.55
Bid27.39 x 900
Ask28.79 x 1800
Day's Range27.24 - 28.70
52 Week Range22.70 - 29.93
Volume2,186,734
Avg. Volume383,390
Market Cap1.821B
Beta0.12
PE Ratio (TTM)N/A
EPS (TTM)-0.22
Earnings DateNov 1, 2017 - Nov 6, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est30.00
Trade prices are not sourced from all markets
  • GlobeNewswire13 hours ago

    B. Braun to Acquire Bloodlines Business of NxStage Medical, Inc.

    BETHLEHEM, Pa., July 19, 2018-- B. Braun Medical Inc., a market leader in renal therapies, infusion therapy, and pain management, has signed an agreement to acquire the bloodlines business operated under ...

  • Benzinga14 hours ago

    Benzinga's Daily Biotech Pulse: Novartis Licenses Skin Drug, 2 Stocks To Debut

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 18) Abbott Laboratories (NYSE: ABT )(reported better-than-expected ...

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit13 days ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • ACCESSWIRE23 days ago

    Complimentary Technical Snapshots on Merit Medical Systems and Three More Medical Supplies Stocks

    Ahead of today's trading session, WallStEquities.com features the Medical Instruments and Supplies manufacturing industry, which primarily researches, develops, and produces nonelectronic medical, surgical, dental, and veterinary instruments and apparatus, such as syringes, anesthesia apparatus, and blood transfusion equipment.Under evaluation this morning are these four stocks: Mazor Robotics Ltd (NASDAQ: MZOR), Merit Medical Systems Inc. (NASDAQ: MMSI), Nxstage Medical Inc. (NASDAQ: NXTM), and Sientra Inc. (NASDAQ: SIEN). All you have to do is sign up today for this free limited time offer by clicking the link below.

  • ACCESSWIRE2 months ago

    Free Daily Technical Summary Reports on Valeritas and Three Other Medical Supplies Stocks

    Stock Research Monitor: ILMN, NXTM, and SIEN LONDON, UK / ACCESSWIRE / May 22, 2018 / If you want a free Stock Review on VLRX sign up now at www.wallstequities.com/registration . For today, WallStEquities.com ...

  • NxStage Keeps Losing Money as Key Deadline Grows Nearer
    Motley Fool2 months ago

    NxStage Keeps Losing Money as Key Deadline Grows Nearer

    Find out why concerns about the dialysis specialist's merger are getting worse.

  • NxStage Medical (NXTM) Q1 2018 Earnings Conference Call Transcript
    Motley Fool2 months ago

    NxStage Medical (NXTM) Q1 2018 Earnings Conference Call Transcript

    NXTM earnings call for the period ending March 31, 2018.

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    NxStage Medical Inc NASDAQ/NGS:NXTM

  • GlobeNewswire2 months ago

    Consolidated Research: 2018 Summary Expectations for The Mosaic, Newmont Mining, National Oilwell Varco, NxStage Medical, Public Service Enterprise Group, and PRA Health Sciences — Fundamental Analysis, Key Performance Indications

    NEW YORK, May 08, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The ...

  • ACCESSWIRE3 months ago

    Wired News - US Release of MasterGuard(R) Plus Announced by Nxstage Medical

    Stock Monitor: Milestone Scientific Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 17, 2018 / Active-Investors.com has just released a free research report on Nxstage Medical, Inc. (NASDAQ: NXTM ...

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit3 months ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    NxStage Medical Inc NASDAQ/NGS:NXTM

  • Medisystems Announces US Release of MasterGuard® Plus
    PR Newswire3 months ago

    Medisystems Announces US Release of MasterGuard® Plus

    Innovative AVF needle guard includes enhancements designed to prevent needlesticks LAWRENCE, Mass. , April 13, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company ...

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit4 months ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    NxStage Medical Inc NASDAQ/NGS:NXTM

  • NxStage Celebrates Fifth Annual National Home Hemodialysis Day
    PR Newswire4 months ago

    NxStage Celebrates Fifth Annual National Home Hemodialysis Day

    Company lights Boston's Zakim Bridge and boosts educational awareness efforts on the benefits of home hemodialysis and more frequent therapy. LAWRENCE, Mass., March 15, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), the manufacturer of the NxStage® System One™ home hemodialysis system, is celebrating the fifth annual Home Hemodialysis (HHD) Day on March 15, 2018. Annually observed during National Kidney Month, this initiative focuses on raising awareness of home hemodialysis and more frequent therapy as a viable treatment option for patients requiring dialysis.

  • Seven Unique NxStage Abstracts Presented During the 38th Annual Dialysis Conference
    PR Newswire4 months ago

    Seven Unique NxStage Abstracts Presented During the 38th Annual Dialysis Conference

    LAWRENCE, Mass., March 13, 2018 /PRNewswire/ -- NxStage Medical, Inc. (NXTM), a leading medical technology company focused on advancing renal care, announced new findings further demonstrating the benefits of home hemodialysis with the NxStage® System One™, including on-site hemodialysis at skilled nursing facilities, solo home hemodialysis, and more frequent home hemodialysis. Eric Weinhandl, PhD, MS, NxStage Clinical Epidemiologist and Adjunct Assistant Professor at the University of Minnesota, presented a study of hospitalization and related Medicare expenditures in the roughly 8,000 nursing home residents per year who initiated dialysis.

  • Why Abiomed’s Product Pipeline Looks Promising
    Market Realist5 months ago

    Why Abiomed’s Product Pipeline Looks Promising

    Abiomed (ABMD) is strategically focused on the market penetration of the company’s family of Impella heart pumps. The Impella device portfolio consists of Impella 2.5, Impella CP, Impella RP, Impella LD, and Impella 5.0 devices. To this end, Abiomed discontinued the sale of its AB5000 device used for heart surgery.

  • What Analysts Recommend for Abiomed and Peers in February 2018
    Market Realist5 months ago

    What Analysts Recommend for Abiomed and Peers in February 2018

    Abiomed (ABMD) is a supplier of mechanical circulatory support devices and offers a continuum of care to heart failure patients. Abiomed develops, manufactures, and commercializes products designed to improve the blood flow and perform the pumping function of the heart. Of the ten analysts covering Abiomed (ABMD) in February 2018, five analysts have given the stock a “strong buy” rating, three analysts have given it a “buy” rating, while two analysts have given it a “hold” rating.

  • Wider Losses Worry NxStage Medical Shareholders
    Motley Fool5 months ago

    Wider Losses Worry NxStage Medical Shareholders

    An increasing discount to the buyout price for the dialysis specialist's stock is raising concerns.

  • A Look at NxStage Medical’s Business Strategy
    Market Realist5 months ago

    A Look at NxStage Medical’s Business Strategy

    At present, in-center hemodialysis is the predominant ESRD (end stage renal disease) therapy in the United States. According to NxStage Medical (NXTM), ~10%–15% of ESRD patients in the United States would be appropriate candidates for the company’s home dialysis equipment, System One. According to Centers for Medicare and Medicaid (or CMS), only 18% of dialysis clinics in the United States actively offer home hemodialysis for patients, and only 27% are certified to offer this therapy.

  • Insight into the NxStage Medical–Fresenius Medical Care Merger
    Market Realist5 months ago

    Insight into the NxStage Medical–Fresenius Medical Care Merger

    Since its inception, NxStage Medical (NXTM) has focused on creating a long-term sustainable model driven by innovative technologies. Although NxStage Medical has witnessed revenue growth, it has historically operated at a net loss. It expects the operating income it generates from its products business to continue to be offset by the losses in its kidney care business and the costs associated with its merger with Fresenius Medical Care Holdings (FAS).

  • Analysts’ Ratings for NxStage Medical and Peers in February 2018
    Market Realist5 months ago

    Analysts’ Ratings for NxStage Medical and Peers in February 2018

    Headquartered in Lawrence, Massachusetts, NxStage Medical (NXTM) is a medical technology company with a focus on developing, manufacturing, and marketing innovative products targeted at patients suffering from chronic or acute kidney failure. The company also operates NxStage kidney care dialysis centers, which treat end-stage renal disease (or ESRD) patients. NxStage Medical’s primary product is System One, which is capable of delivering the therapeutic flexibility and clinical benefits of traditional dialysis machines in a smaller, portable, and easy-to-use format.

  • See what the IHS Markit Score report has to say about NxStage Medical Inc.
    Markit5 months ago

    See what the IHS Markit Score report has to say about NxStage Medical Inc.

    NxStage Medical Inc NASDAQ/NGS:NXTM